Skip to main content

Table 6 Frequency of MEFV gene mutations in responder group and non-responder group

From: Colchicine versus cimetidine: the better choice for Periodic fever, aphthous stomatitis, pharyngitis, adenitis (PFAPA) syndrome prophylaxis, and the role of MEFV gene mutations

 

variable

Responder group

Nonresponder group

total

*P-value

MEFV mutation

Cimetidine

Carriers (number)

4 (36%)

1 (14%)

5 (28%)

1

Non Carriers (number)

7(64%)

6 (86%)

13 (72%)

colchicine

Carriers (number)

7(41%)

4(44%)

11(42%)

1

Non Carriers (number)

10(59%)

5(56%)

15(58%)

  1. *Fisher’s Exact Test